HM
NGM

HealthCor Management’s NGM Biopharmaceuticals, Inc. Common Stock NGM Stock Holding History

HealthCor Management’s Portfolio NGM Stock Details NGM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-316,679
Closed -$4.39M – 68
2019
Q3 		$4.39M Sell
316,679
-25,900
-8% -$389K 0.17% 50
2019
Q2 		$5.01M Buy
+342,579
New +$5.01M 0.19% 48

Other funds holding NGM

PS
Peter Svennilson $1.23B AUM 301.34% 1-Year Est. Return
RCP
Rho Capital Partners New York $20.4M AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GA
Greenspring Associates Owings Mills, Maryland $1.48B AUM 61.93% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
JRP
Jasper Ridge Partners Menlo Park, California $4.49B AUM 18.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

HealthCor Management's NGM Position: Q4 2019 in Review

HealthCor Management sold out of NGM Biopharmaceuticals, Inc. Common Stock (NGM) in Q4 2019, closing a stake of 316,679 shares — an estimated $4.39M sold.

HealthCor Management first reported a position in NGM in Q2 2019 and held it in 2 quarters. The position peaked at $5.01M in Q2 2019. 59 funds tracked by Wall St. Rank hold NGM as of Q4 2019.

  • HealthCor Management reported no remaining NGM Biopharmaceuticals, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
  • HealthCor Management sold 316,679 NGM Biopharmaceuticals, Inc. Common Stock shares in Q4 2019, an estimated $4.39M.
  • HealthCor Management first reported a position in NGM Biopharmaceuticals, Inc. Common Stock in Q2 2019 and held it in 2 quarters.
  • HealthCor Management's NGM Biopharmaceuticals, Inc. Common Stock position peaked at $5.01M in Q2 2019.
  • 59 funds tracked by Wall St. Rank held NGM Biopharmaceuticals, Inc. Common Stock as of Q4 2019.

Based on HealthCor Management's 13F filing for Q4 2019, filed 14 Feb 2020.